Pappas Ventures
Creating, guiding, connecting and funding innovative life science companies, from concept to commercialization — the firm’s flagship venture investing practice.
Learn moreHome · About
Who We Are
Proven Leaders in Advancing Life Science.
For 32 years Pappas Capital has been investing in and building innovative companies developing the next generation of life science products and technologies — investing in life science with the goal of improving the lives of patients, while delivering superior results to investors.
32
Years advancing life science
100+
Companies created, funded & guided
$800M+
Managed & deployed for investors
US · Canada · Asia
Where we invest
Founded in 1994 in Durham, North Carolina by Art Pappas — formerly a CEO of international operations at Glaxo Holdings plc — Pappas Capital is a life-sciences venture capital and commercial-development firm dedicated to furthering life science discoveries and bringing groundbreaking solutions to market.
Over more than three decades, the firm has managed more than $800 million and invested in 100+ companies across the United States, Canada, and Asia — spanning next-generation biopharma and therapeutics, medical devices and diagnostics, agriculture, and technology.
Measured in patients reached
Pappas-backed companies have brought products to market for melanoma, ovarian cancer, and hemophilia — treatments used worldwide by tens of thousands of patients and accounting for billions of dollars in revenue. That patients-first standard is how the firm measures its work: not only in returns delivered, but in lives improved.
What We Do
Three ways we advance life science.
Affiliations & certifications
Building the next generation of life science.
Whether you are an entrepreneur with a breakthrough or an investor seeking exposure to life science, we would like to hear from you.
Durham, North Carolina